LivaNova introduces SenTiva DUO
LivaNova, a leading medical tech and innovation firm, launches SenTiva DUO, an IPG with dual-pin header for treatment of drug-resistant epilepsy via VNS Therapy. SenTiva DUO distinguishes itself from the original SenTiva (single-pin) and provides latest VNS Therapy technology to patients originally implanted with dual-pin lead and IPG.